Ignite Creation Date:
2025-12-25 @ 4:29 AM
Ignite Modification Date:
2025-12-26 @ 3:32 AM
Study NCT ID:
NCT04129320
Status:
WITHDRAWN
Last Update Posted:
2022-02-08
First Post:
2019-10-14
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Enoblituzumab Plus MGA012 or MGD013 in Squamous Cell Carcinoma of the Head and Neck
Sponsor:
MacroGenics
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-10
Start Date Type:
ESTIMATED
Primary Completion Date:
2020-10
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-10
Completion Date Type:
ESTIMATED
First Submit Date:
2019-10-14
First Submit QC Date:
None
Study First Post Date:
2019-10-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-02-04
Last Update Post Date:
2022-02-08
Last Update Post Date Type:
ACTUAL